Related Experiment Videos
Selective removal of fast-dissociating antibodies from a high-affinity antiserum
Molecular Immunology
|March 1, 1980
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
The British journal of dermatology·2014
Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2014
Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions.
Journal of clinical pharmacy and therapeutics·2014
Imaging requirements for personalized medicine: the oncologists point of view.
Current pharmaceutical design·2013
Nephrotoxicity of anticancer drugs--an underestimated problem?
Acta clinica Belgica·2011
Exploring the relationship between natural and cryptic polyreactivity in human antibodies.
Molecular immunology·2026
Bacillus Calmette-Guerin in controlling type 1 diabetes: A quasi-experimental randomized clinical trial.
Caspian journal of internal medicine·2026
Telemedicine-guided management of iodinated contrast media-associated anaphylaxis: A case report.
Radiology case reports·2026
Hybridoma-based generation of a functional IgM antibody targeting the 160-loop of influenza B virus haemagglutinin.
Journal of immunological methods·2026
Management of hyperthyroidism in pregnancy.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2026
Photodynamic activities of silicon (IV) phthalocyanines with different charges and their synergistic efficacy with immunotherapy.
International immunopharmacology·2026